Other
Hypospadias
27
Pipeline Programs↗
7
Active Trials↗
11
Companies Involved↗
Hypospadias is an emerging landscape with 27 programs across 11 companies. The most active players are TLC Biopharmaceuticals, Inc., Merck & Co., McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.. 12 therapies are approved with 6 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical5
Phase 36
Analysis
Trial Status
27
clinical trials
Completed10 · 37%
Unknown status8 · 30%
Recruiting4 · 15%
Not yet recruiting2 · 7%
Active, not recruiting1 · 4%
Withdrawn1 · 4%
Other1 · 4%
Clinical Trials
Trial Activity
27 trials
Prophylactic Antibiotics or Placebo After Hypospadias Repair
Active, not recruiting·—·N/A·NCT02096159·93 enrolled
Comparison of the Efficacy of Bupivacaine with and Without Dexmedetomidine As an Adjuvant on Penile Block for Postoperative Pain Relief in Pediatrics Undergoing Hypospadias Repair Surgery
Not yet recruiting·—·Phase 3·NCT06789393·80 enrolled
Preventative Effect of Combining Dexamethasone with Ondansetron on Postoperative Nausea, Vomiting and Shivering in Children Undergoing Caudal Anesthesia on Hypospadias Surgery
Not yet recruiting·—·Phase 4·NCT06747975·100 enrolled
Caudal Combination of Dexamethasone and/or Dexmedetomidine to Bupivacaine in Pediatric Hypospadias Surgery
Completed·—·Phase 1·NCT03261921·63 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)